Oseltamivir resistance during treatment of influenza A (H5N1) infection - Test2 - elhamkhani - TriplyDB

Oseltamivir resistance during treatment of influenza A (H5N1) infection

Oseltamivir resistance during treatment of influenza A (H5N1) infection

http://www.wikidata.org/entity/Q29618722

about

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases Influenza virus antigenic variation, host antibody production and new approach to control epidemics Systematic review of influenza resistance to the neuraminidase inhibitors Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors Neuraminidase inhibitors for preventing and treating influenza in healthy adults Neuraminidase inhibitors for preventing and treating influenza in healthy adults Pandemic potential of a strain of influenza A (H1N1): early findings Antiviral drugs for viruses other than human immunodeficiency virus Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses Survival of influenza virus on banknotes.Current and future antiviral therapy of severe seasonal and avian influenza Inefficient transmission of H5N1 influenza viruses in a ferret contact model Pandemic influenza: risk of multiple introductions and the need to prepare for them.Modeling human influenza infection in the laboratory Clinical Implications of Antiviral Resistance in Influenza Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies H5N1 vaccines in humans Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection Broad-Spectrum Drugs Against Viral Agents Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses Changes in the hemagglutinin of H5N1 viruses during human infection – Influence on receptor binding Synthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylate Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir Reverse Genetics Approaches for the Development of Influenza Vaccines Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection Influenza viruses: breaking all the rules A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells Antiviral resistance and the control of pandemic influenza A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread

P2860

Q21142658-79AEB7FD-1F5F-4605-9E80-5E4C632FC7EA Q21142689-EB554C34-6973-406B-9DDB-FCFE5AD18444 Q21245119-3DBC3922-79BA-416F-8450-464857AC5E6E Q21261835-08E02701-BFED-491C-9485-0E1534B91589 Q21562299-12AAB8E8-F879-4EA8-9905-2A44D7ED1854 Q21562507-9E0A3DE2-8441-442A-B62E-CF1CC8D35D89 Q21563426-1FD5EB1A-6A8D-46A0-A6CC-F097C7D38B82 Q22255463-A2B6B7AE-D825-4843-8B23-8E3F1F914729 Q22305941-42AF4500-2030-486E-A560-C556BBB67A57 Q24240097-90EFD94B-8E87-450E-A51A-2DB7B3971187 Q24244898-B5A69D7B-8C03-45F9-A1A8-6FBFAFDC7150 Q24286924-B77D6F34-AFD1-4C49-BA3D-F03093358676 Q24635330-BB8C903A-B492-471F-BB1E-64BAF649BFF1 Q24645944-E820B0C6-C426-4B76-8AF2-6BDBD1AFA747 Q24649949-BBCCF6F5-7367-493E-972E-D2DF457444D4 Q24650616-72192D4D-777E-4DAD-BB18-FACA95D2B7FC Q24656164-E52426AF-E3C6-42A9-A04C-FCD765BA3616 Q24684249-813C9411-6B08-4014-8A12-D570F35AA4F2 Q25255931-EAE8B7FF-320B-411E-80B9-5F9FFF14BCC6 Q26781842-8BF07FFA-6A9D-456A-8E10-DCDC912585E1 Q26782746-43F79A8D-06F4-43CF-ABE5-E2008B8C9668 Q26823492-80706180-88B2-49C1-A1C7-A8360397F8C9 Q27000896-21862E53-BC24-4EAD-AE64-E5DAFE266777 Q27314689-154A0AC0-80BB-43AE-ACC4-C8CB4C790F40 Q27324824-F00BBBC4-ECF5-4BB5-97EB-3D4FB4EDF438 Q27487859-A9046DD0-6CFD-4FF2-B6E3-1B748C57D19B Q27644686-D286C585-6BB4-47CC-84F5-0E979E6FC1FA Q27663966-1D0D80D8-9172-4E26-A60A-21DCCBD1A217 Q27679989-B022569E-EDF8-4C9A-BDF1-9FBD968D87EC Q27688897-A1AF29D4-E262-4654-8DCC-217A5424C1DD Q28066861-B96678AA-8533-4AE0-81FA-F751DCD31F32 Q28076140-2AEB3E02-FE72-438A-9B60-608AAEECA19E Q28262914-7FFB015F-690F-4785-88E4-47044C75AE5D Q28282405-121CE3DB-D32E-4D8D-84F3-D83904A9BFA5 Q28308105-8B1D1986-122A-4A0C-B5E7-11C0311E0730 Q28386965-E33C09FA-E784-49BA-AED9-7340DF2A99B8 Q28390286-EB3809E7-04BA-40E0-9382-EE54FC0E226C Q28469119-622BB17A-7093-4CA4-AE54-FD208E9E2D71 Q28471710-EC1125CD-AEB4-460E-9BD5-A37FD294415B Q28471814-28956A34-FDD6-4078-A4F3-E4BCBF8E40B6

P2860

Oseltamivir resistance during treatment of influenza A (H5N1) infection

http://www.wikidata.org/entity/Q29618722

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Oseltamivir resistance during treatment of influenza A (H5N1) infection

@ast

Oseltamivir resistance during treatment of influenza A (H5N1) infection

@en

type

label

Oseltamivir resistance during treatment of influenza A (H5N1) infection

@ast

Oseltamivir resistance during treatment of influenza A (H5N1) infection

@en

prefLabel

Oseltamivir resistance during treatment of influenza A (H5N1) infection

@ast

Oseltamivir resistance during treatment of influenza A (H5N1) infection

@en

P1433

Q29618722-C4F6DED9-2616-4C31-9E82-67E921018060

P1476

Q29618722-B09A19E5-B7B3-4141-904D-0A96F4DDBA5D

P2093

Q29618722-06ED4596-C83C-42F9-B9C2-162FC9BEED6D

Q29618722-0FEA376F-97AC-4753-ACBF-3E0F8BDCB227

Q29618722-17B5E2DE-0E58-4DAF-BD5B-89415BEA3FF4

Q29618722-511AAEDE-E3CA-4F74-B282-AC9EEE97EA30

Q29618722-73F87131-3E9F-4BBF-BD5B-0B670B96046D

Q29618722-C34A990E-8B46-4CB6-A552-9903BAEF204F

Q29618722-CFF4F1FC-28D5-42C2-ACB2-E65C589D1962

Q29618722-D928D04C-7DA6-4348-8CAF-B7BBB876EF1C

Q29618722-F530E05F-795F-4D00-956F-6A7179FEA9C5

P304

Q29618722-BF7DE009-E13D-4B6A-89FC-8FD52B1174EC

P31

Q29618722-BBB10705-3E21-4AD2-8A00-7DAA0CA2FBF2

P3181

Q29618722-6B7083FC-95FF-4CF8-99A8-9A4447A79579

P356

Q29618722-9E1B2739-E6C3-4797-BDF8-CED893A03716

P407

Q29618722-06AA7377-E686-4815-B7DF-08EA83100B31

P433

Q29618722-F5744E75-84DD-47F8-8677-79B9032896F6

P478

Q29618722-6F235B3A-88F8-4EE6-8845-97DD532A6005

P50

Q29618722-0367A63E-0848-4A95-BBBA-04FE8C06968F

Q29618722-96B5B959-368A-4FF5-84FD-4B3561768253

Q29618722-AE6C20E8-6ECB-4D63-857E-A049A0C49C01

Q29618722-DA717174-0FE8-4F26-8F93-D48C85A32625

P577

Q29618722-6F51B42C-F9F7-4CD6-B91F-0A5DB906DC05

P5875

Q29618722-EF5AF1D7-53D7-4537-AEB6-1890F8B0596E

P698

Q29618722-2C8C24A6-7006-4C35-B667-DD23FABCA408

P3181

P356

P1433

The New England Journal of Medicine

P1476

Oseltamivir resistance during treatment of influenza A (H5N1) infection

@en

P2093

Huu Khanh Truong

http://www.w3.org/2001/XMLSchema#string

Menno D de Jong

http://www.w3.org/2001/XMLSchema#string

Minh Hien Vo

http://www.w3.org/2001/XMLSchema#string

Quang Ha Do

http://www.w3.org/2001/XMLSchema#string

Tan Thanh Tran

http://www.w3.org/2001/XMLSchema#string

Tinh Hien Tran

http://www.w3.org/2001/XMLSchema#string

Tu Qui Phan

http://www.w3.org/2001/XMLSchema#string

Van Cam Bach

http://www.w3.org/2001/XMLSchema#string

Vinh Chau Nguyen

http://www.w3.org/2001/XMLSchema#string

P304

2667-2672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

130060

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA054512

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

353

http://www.w3.org/2001/XMLSchema#string

P50

Gavin J D Smith

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7398813

http://www.w3.org/2001/XMLSchema#string

P698

16371632

http://www.w3.org/2001/XMLSchema#string